AEON Biopharma, Inc. Quarterly Current Ratio in % from Q3 2021 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
AEON Biopharma, Inc. quarterly Current Ratio history and growth rate from Q3 2021 to Q2 2024.
  • AEON Biopharma, Inc. Current Ratio for the quarter ending June 30, 2024 was 55.3 %, a 393% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 55.3 +44.1 +393% Jun 30, 2024
Q1 2024 49.8 +37.9 +319% Mar 31, 2024
Q4 2023 57 +44.5 +354% Dec 31, 2023
Q3 2023 24.9 -20 -44.6% Sep 30, 2023
Q2 2023 11.2 -82.2 -88% Jun 30, 2023
Q1 2023 11.9 -171 -93.5% Mar 31, 2023
Q4 2022 12.6 -298 -96% Dec 31, 2022
Q3 2022 44.9 -438 -90.7% Sep 30, 2022
Q2 2022 93.4 Jun 30, 2022
Q1 2022 183 Mar 31, 2022
Q4 2021 311 Dec 31, 2021
Q3 2021 483 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.